Skip to main content
Addgene
Showing: 81 - 100 of 182 results

  1. pAAV-mDlx-GFP-Fishell-1 (AAV9)

    Viral Prep
    #83900-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-mDlx-GFP-Fishell-1 (#83900). In addition to the viral particles, you will also receive purified pAAV-mDlx-GFP-Fishell-1 plasmid DNA. mDlx-driven expression of GFP in GABA-ergic interneurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Dimidschstein et al Nat Neurosci. 2016 Oct 31. doi: 10.1038/
    Promoter
    mDlx
    Tags
    GFP
    Available since
    Nov. 13, 2020
    Availability
    Academic Institutions and Nonprofits only

  2. pAAV-CAG-GFP (AAV9 trial size)

    Viral Prep
    #37825-AAV9.T
    Purpose
    Ready-to-use AAV9 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Promoter
    CAG
    Tags
    GFP
    Available since
    May 29, 2019
    Availability
    Academic Institutions and Nonprofits only

  3. AAV-FLEX-Arch-GFP (AAV9)

    Viral Prep
    #22222-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from AAV-FLEX-Arch-GFP (#22222). In addition to the viral particles, you will also receive purified AAV-FLEX-Arch-GFP plasmid DNA. CAG-driven cre-dependent Arch-GFP expression for optogenetic neural inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Article
    Chow et al Nature. 2010 Jan 7. 463(7277):98-102.
    Promoter
    CAG
    Tags
    GFP (Cre-dependent)
    Available since
    Feb. 20, 2018
    Availability
    Academic Institutions and Nonprofits only

  4. pAAV-hSyn-DIO-EGFP (AAV2)

    Viral Prep
    #50457-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    Syn
    Tags
    EGFP (Cre-dependent)
    Available since
    Jan. 17, 2020
    Availability
    Academic Institutions and Nonprofits only

  5. pAAV-hSyn-DIO-EGFP (AAV5)

    Viral Prep
    #50457-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    Syn
    Tags
    EGFP (Cre-dependent)
    Available since
    July 8, 2019
    Availability
    Academic Institutions and Nonprofits only

  6. pAAV-hSyn-EGFP (AAV9 trial size)

    Viral Prep
    #50465-AAV9.T
    Purpose
    Ready-to-use AAV9 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    Syn
    Tags
    EGFP
    Available since
    May 29, 2019
    Availability
    Academic Institutions and Nonprofits only

  7. pAAV-CAG-GFP (AAV CAP-B10)

    Viral Prep
    #37825-CAP-B10
    Purpose
    Ready-to-use AAV CAP-B10 particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV were produced with the CAP-B10 serotype, which permits efficient transduction of both inhibitory and excitatory neurons in the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Promoter
    CAG
    Tags
    GFP
    Available since
    Nov. 8, 2023
    Availability
    Academic Institutions and Nonprofits only

  8. pAAV-hSyn-EGFP (AAV8 trial size)

    Viral Prep
    #50465-AAV8.T
    Purpose
    Ready-to-use AAV8 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    Syn
    Tags
    EGFP
    Available since
    May 29, 2019
    Availability
    Academic Institutions and Nonprofits only

  9. pAAV-mDlx-GFP-Fishell-1 (AAV1)

    Viral Prep
    #83900-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-mDlx-GFP-Fishell-1 (#83900). In addition to the viral particles, you will also receive purified pAAV-mDlx-GFP-Fishell-1 plasmid DNA. mDlx-driven expression of GFP in GABA-ergic interneurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Dimidschstein et al Nat Neurosci. 2016 Oct 31. doi: 10.1038/
    Promoter
    mDlx
    Tags
    GFP
    Available since
    Jan. 26, 2021
    Availability
    Academic Institutions and Nonprofits only

  10. pAAV-hSyn-EGFP (AAV2 trial size)

    Viral Prep
    #50465-AAV2.T
    Purpose
    Ready-to-use AAV2 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    Syn
    Tags
    EGFP
    Available since
    July 31, 2019
    Availability
    Academic Institutions and Nonprofits only

  11. pAAV-hSyn-EGFP (AAV5 trial size)

    Viral Prep
    #50465-AAV5.T
    Purpose
    Ready-to-use AAV5 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    Syn
    Tags
    EGFP
    Available since
    June 12, 2019
    Availability
    Academic Institutions and Nonprofits only

  12. pAAV-CAG-GFP (AAV8 trial size)

    Viral Prep
    #37825-AAV8.T
    Purpose
    Ready-to-use AAV8 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Promoter
    CAG
    Tags
    GFP
    Available since
    May 29, 2019
    Availability
    Academic Institutions and Nonprofits only

  13. pAAV-Syn-Chronos-GFP (AAV5)

    Viral Prep
    #59170-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-Syn-Chronos-GFP (#59170). In addition to the viral particles, you will also receive purified pAAV-Syn-Chronos-GFP plasmid DNA. Syn-driven Chronos-GFP expression for optogenetic neural activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Article
    Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:
    Promoter
    Syn
    Tags
    GFP
    Available since
    July 21, 2017
    Availability
    Academic Institutions and Nonprofits only

  14. pAAV-FLEX-DTR-GFP (AAV2)

    Viral Prep
    #124364-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-FLEX-DTR-GFP (#124364). In addition to the viral particles, you will also receive purified pAAV-FLEX-DTR-GFP plasmid DNA. CBA-driven, Cre-dependent expression of DTR-GFP. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Thomas Jessell, Eiman Azim
    Article
    Azim et al Nature. 2014 Apr 17;508(7496):357-63. do
    Promoter
    Chicken B-actin
    Tags
    GFP (Cre-dependent)
    Available since
    June 16, 2020
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV-Syn-Chronos-GFP (AAV1)

    Viral Prep
    #59170-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-Syn-Chronos-GFP (#59170). In addition to the viral particles, you will also receive purified pAAV-Syn-Chronos-GFP plasmid DNA. Syn-driven Chronos-GFP expression for optogenetic neural activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Article
    Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:
    Promoter
    Syn
    Tags
    GFP
    Available since
    Feb. 7, 2018
    Availability
    Academic Institutions and Nonprofits only

  16. pAAV_hSyn-PdCO-EGFP-WPRE (AAV5)

    Viral Prep
    #198513-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV_hSyn-PdCO-EGFP-WPRE (#198513). In addition to the viral particles, you will also receive purified pAAV_hSyn-PdCO-EGFP-WPRE plasmid DNA. Synapsin-driven expression of the optimized opsin PdCO in frame with EGFP. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Ofer Yizhar
    Article
    Wietek et al Nat Methods. 2024 May 29. doi: 10.1038/s
    Promoter
    Syn
    Tags
    EGFP
    Available since
    April 10, 2024
    Availability
    Academic Institutions and Nonprofits only

  17. pAAV-hSynapsin- soCoChR-GFP (AAV9)

    Viral Prep
    #107708-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hSynapsin- soCoChR-GFP (#107708). In addition to the viral particles, you will also receive purified pAAV-hSynapsin- soCoChR-GFP plasmid DNA. Synapsin-driven somatic CoChR (soCoChR) fused to GFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Article
    Shemesh et al Nat Neurosci. 2017 Dec;20(12):1796-1806.
    Promoter
    Syn
    Tags
    GFP
    Available since
    Sept. 7, 2018
    Availability
    Academic Institutions and Nonprofits only

  18. AAV-FLEX-Arch-GFP (AAV1)

    Viral Prep
    #22222-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from AAV-FLEX-Arch-GFP (#22222). In addition to the viral particles, you will also receive purified AAV-FLEX-Arch-GFP plasmid DNA. CAG-driven cre-dependent Arch-GFP expression for optogenetic neural inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Article
    Chow et al Nature. 2010 Jan 7. 463(7277):98-102.
    Promoter
    CAG
    Tags
    GFP (Cre-dependent)
    Available since
    Feb. 21, 2018
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV-mDlx-GFP-Fishell-1 (AAV5)

    Viral Prep
    #83900-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-mDlx-GFP-Fishell-1 (#83900). In addition to the viral particles, you will also receive purified pAAV-mDlx-GFP-Fishell-1 plasmid DNA. mDlx-driven expression of GFP in GABA-ergic interneurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Dimidschstein et al Nat Neurosci. 2016 Oct 31. doi: 10.1038/
    Promoter
    mDlx
    Tags
    GFP
    Available since
    Aug. 25, 2023
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV-mDlx-GFP-Fishell-1 (AAV2)

    Viral Prep
    #83900-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-mDlx-GFP-Fishell-1 (#83900). In addition to the viral particles, you will also receive purified pAAV-mDlx-GFP-Fishell-1 plasmid DNA. mDlx-driven expression of GFP in GABA-ergic interneurons. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Gordon Fishell
    Article
    Dimidschstein et al Nat Neurosci. 2016 Oct 31. doi: 10.1038/
    Promoter
    mDlx
    Tags
    GFP
    Available since
    Aug. 25, 2023
    Availability
    Academic Institutions and Nonprofits only
Showing: 81 - 100 of 182 results